Vestar acquires MediMedia USA

Share this article:
MediMedia USA has changed hands as a private equity consortium. Ciniven, Apax Partners and The Carlyle Group agreed to sell the publisher to New York-based Vestar Capital Partners for just under 500 million euros ($634 million), including debt assumed.

The consortium, which bought the firm from Vivendi in 2002, was advised by Goldman Sachs, and said it made 3.2 times its original equity investment of 250 million euros ($316 million). Vestar was advised by DeSilva & Phillips.

Headquartered in Chatham, NJ, MediMedia boasts 1,400 employees managing its titles, patient education and health management programs.  

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...